Crossmark

The nationwide survey of Japanese public opinion about off-label use of anticancer drugs recommended by comprehensive genomic profiling

Published Online: 2025-07-18

Published Print: 2025-09

Authors

Matsubara, Junichi https://orcid.org/0000-0003-0116-5133
Mukai, Kumi

Muto, Manabu
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP23lk0221166)
License Information

Text and Data Mining valid from 2025-07-18

Version of Record valid from 2025-07-18
More Information

Article History

Received: 9 April 2025

Accepted: 1 June 2025

First Online: 18 July 2025

Declarations

:

: All authors have no conflicts of interest in relation to this study. Manabu Muto is a director of the Japan Society of Clinical Oncology.

: Approval of the research protocol by an Institutional Reviewer Board: N/A. Registration no. of the study: N/A.

Document is current